Emergent BioSolutions (LTS:0IGA) Cash Flow from Discontinued Operations : $0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Emergent BioSolutions Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Emergent BioSolutions's cash flow from discontinued operations for the three months ended in Mar. 2025 was $0.0 Mil. It means Emergent BioSolutions received $0.0 Mil from the sale of part of business quarterly. Emergent BioSolutions's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was $0.0 Mil.

Emergent BioSolutions Cash Flow from Discontinued Operations Historical Data

The historical data trend for Emergent BioSolutions's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Cash Flow from Discontinued Operations Chart

Emergent BioSolutions Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Emergent BioSolutions Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Emergent BioSolutions Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Emergent BioSolutions Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Emergent BioSolutions's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent BioSolutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (LTS:0IGA) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

EBS:USA ER4:Germany

Address

300 Professional Drive, Gaithersburg, MD, USA, 20879

Website

https://www.emergentbiosolutions.com

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Emergent BioSolutions Headlines

No Headlines